Have a personal or library account? Click to login
Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients Cover

Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients

Radiology and Oncology
Volume 53 (2019): Issue 1 (March 2019)
By: Martina Rebersek,  Tanja Mesti,  Marko Boc and  Janja Ocvirk  
Open Access
|Mar 2019
DOI: https://doi.org/10.2478/raon-2019-0013 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 85 - 95
Submitted on: Aug 30, 2018
Accepted on: Sep 20, 2018
Published on: Mar 3, 2019
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
metastatic colorectal cancer,
chemotherapy,
targeted therapy,
histological parameters,
biomarkers
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2019 Martina Rebersek, Tanja Mesti, Marko Boc, Janja Ocvirk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 53 (2019): Issue 1 (March 2019)Next article